普洛药业(000739.SZ)：头孢托仑匹酯获得化学原料药上市申请批准

智通财经09-09

智通财经APP讯，普洛药业(000739.SZ)发布公告，近日，公司全资子公司浙江普洛得邦制药有限公司收到国家药品监督管理局(以下简称“药监局”)签发的头孢托仑匹酯的《化学原料药上市申请批准通知书》。此次公司头孢托仑匹酯原料药的获批上市，标志着公司该产品具备了在国内市场的销售资格，拓宽了公司的产品管线，有助于进一步拓展公司原料药业务，进一步推进做精原料的业务发展战略，对公司未来发展具有一定的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2666358148?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-09 17:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2666358148","market":"hk","top_or_hot":-1,"title":"普洛药业(000739.SZ)：头孢托仑匹酯获得化学原料药上市申请批准","media":"智通财经","content":"<div>\n<p>智通财经APP讯，普洛药业(000739.SZ)发布公告，近日，公司全资子公司浙江普洛得邦制药有限公司收到国家药品监督管理局(以下简称“药监局”)签发的头孢托仑匹酯的《化学原料药上市申请批准通知书》。此次公司头孢托仑匹酯原料药的获批上市，标志着公司该产品具备了在国内市场的销售资格，拓宽了公司的产品管线，有助于进一步拓展公司原料药业务，进一步推进做精原料的业务发展战略，对公司未来发展具有一定的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1493949.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>普洛药业(000739.SZ)：头孢托仑匹酯获得化学原料药上市申请批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n普洛药业(000739.SZ)：头孢托仑匹酯获得化学原料药上市申请批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-09 17:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1493949.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，普洛药业(000739.SZ)发布公告，近日，公司全资子公司浙江普洛得邦制药有限公司收到国家药品监督管理局(以下简称“药监局”)签发的头孢托仑匹酯的《化学原料药上市申请批准通知书》。此次公司头孢托仑匹酯原料药的获批上市，标志着公司该产品具备了在国内市场的销售资格，拓宽了公司的产品管线，有助于进一步拓展公司原料药业务，进一步推进做精原料的业务发展战略，对公司未来发展具有一定的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1493949.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1493949.html","article_id":"2666358148","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2666358148","pubTimestamp":1788947084,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，普洛药业(000739.SZ)发布公告，近日，公司全资子公司浙江普洛得邦制药有限公司收到国家药品监督管理局(以下简称“药监局”)签发的头孢托仑匹酯的《化学原料药上市申请批准通知书》。此次公司头孢托仑匹酯原料药的获批上市，标志着公司该产品具备了在国内市场的销售资格，拓宽了公司的产品管线，有助于进一步拓展公司原料药业务，进一步推进做精原料的业务发展战略，对公司未来发展具有一定的积极意义。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0188":"融资融券","IPOS":"Renaissance International IPO ETF","BK0060":"抗癌","000739":"普洛药业","BK0239":"医药制造"},"translate_title":"Progen Pharmaceuticals (000739.SZ): Cefitorenpixil receives approval for its chemical raw material marketing application.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IPOS":1.5,"000739":1.5},"content_text":"智通财经APP讯，普洛药业(000739.SZ)发布公告，近日，公司全资子公司浙江普洛得邦制药有限公司收到国家药品监督管理局(以下简称“药监局”)签发的头孢托仑匹酯的《化学原料药上市申请批准通知书》。此次公司头孢托仑匹酯原料药的获批上市，标志着公司该产品具备了在国内市场的销售资格，拓宽了公司的产品管线，有助于进一步拓展公司原料药业务，进一步推进做精原料的业务发展战略，对公司未来发展具有一定的积极意义。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2666358148","isCrawlerRequest":true}